U.S. Capital Wealth Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$653K Buy
3,768
+1,672
+80% +$343K 0.02% 616
2025
Q4
$537K Buy
2,096
+749
+56% +$196K 0.01% 639
2025
Q3
$350K Buy
1,347
+324
+32% +$85.2K 0.01% 725
2025
Q2
$250K Buy
+1,023
New +$255K 0.01% 772
2023
Q2
Sell
-1,207
Closed -$586K 674
2023
Q1
$586K Buy
1,207
+1,138
+1,649% +$563K 0.03% 399
2022
Q4
$35.3K Buy
+69
New +$36.3K ﹤0.01% 963
2021
Q4
Sell
-689
Closed -$268K 735
2021
Q3
$268K Buy
+689
New +$292K 0.01% 631

Other funds holding HUM

U.S. Capital Wealth Advisors's HUM Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Humana (HUM) stake by 80% in Q1 2026, buying an estimated $343K and bringing the position to 3,768 shares worth $653K. The position accounts for 0.02% of the portfolio, ranked #616.

U.S. Capital Wealth Advisors first reported a position in HUM in Q3 2021 and has held it in 7 quarters since. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • U.S. Capital Wealth Advisors held 3,768 shares of Humana worth $653K as of Q1 2026.
  • U.S. Capital Wealth Advisors bought 1,672 Humana shares in Q1 2026, an estimated $343K.
  • Humana made up 0.02% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #616 holding.
  • U.S. Capital Wealth Advisors first reported a position in Humana in Q3 2021 and has held it in 7 quarters since.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.